DPA International on MSN2d
Germany's BioNTech to buy Chinese firm with promising cancer drugGermany pharmaceutical company BioNTech, which shot to global prominence after its early coronavirus vaccine, has boosted its ...
For the past three years, biotechs and pharmas have renamed, rebranded and more in a bid to refresh their corporate appeal. ...
YORVIPATH launching in U.S. with product availability expected mid-January 2025; ex-U.S. YORVIPATH revenue of €8.5 million in Q3– TransCon CNP ...
With finals approaching, students may struggle with mounting stress and the risk of falling behind, as the pressure begins to ...
NEW YORK, Nov. 13, 2024 /PRNewswire/ -- Fourth Frontier, a medical technology company based out of New York and Bangalore, announced the 510(k) clearance of the Frontier X Plus from the U.S. FDA. The ...
SOL-1 expected to be fully randomized by YE 2024 with topline data expected in Q4 2025 Active clinical trial sites now enrolling patients d ...
BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer ...
Brad Brooks, the singer in late MC5 guitarist Wayne Kramer's "reanimation" of the revolutionary proto-punk band, recently ...
The Food and Drug Administration approved Revuforj from Syndax (SNDX) Pharmaceuticals, a menin inhibitor, for relapsed or refractory acute ...
Federal officials have updated the number of patients in an outbreak of E. coli O157:H7 infections traced to slivered onions on McDonald’s Quarter Pounder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback